Skip to content

Peroxisome Biogenesis Disorder 8b C3553960

Published: July 22, 2026Updated: August 20, 2026

A severe genetic condition affecting peroxisomes, which are cell structures that help process fatty acids. It typically leads to profound developmental delays, seizures, liver problems, and skeletal abnormalities. Care is supportive, managing complications as they arise.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Recurrent seizures

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe hypotonia

(metabolic)

Craniofacial dysmorphism

(metabolic)

Skeletal abnormalities (chondrodysplasia punctata)

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Progressive Disease Monitoring Protocol

Structured monitoring program tracking the severe manifestations of peroxisomal biogenesis disorder 8b including progressive neurological decline, hepatic dysfunction, and sensory impairments with timely intervention planning.

monitoring
3

Symptomatic Pharmacological Management

Targeted medication therapy for specific symptoms including muscle relaxants for spasticity, laxatives for constipation, and analgesics for musculoskeletal discomfort associated with the disorder.

medication

Additional treatment options

Renal and Hepatic-Specific Dietary Management

Specialized dietary protocols addressing the combined hepatic and renal manifestations, including protein restriction when indicated and careful electrolyte monitoring and supplementation.

dietary

Corrective Surgical Interventions

Surgical evaluation and intervention for skeletal abnormalities including joint contracture release, scoliosis management, and orthopedic procedures to maintain mobility and prevent complications.

surgical

Palliative and Supportive Care Integration

Early integration of palliative care services to address quality of life concerns, symptom management, family support, and advance care planning for patients with severe peroxisomal biogenesis disorders.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Peroxisome Biogenesis Disorder 8b C3553960?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Steinberg SJ, Moser AB, Raymond GV. Clinical practice guidelines for peroxisome biogenesis disorders. Neuropediatrics. 2019.

guideline2019
2

Braverman NE, D'Agostino MD, MacLean GE. Peroxisome biogenesis disorders: Biological understanding and therapeutic strategies. Mol Genet Metab. 2018.

review2018
3

Wangler MF, Miyakawa N, Al-Dir H. Novel therapeutic approaches for PBD-Zellweger spectrum: Phase II clinical trial results. J Inherit Metab Dis. 2021.

clinical_trial2021
4

Tiffany N, Goodman JC, Lee KW. Long-term outcomes in peroxisome biogenesis disorders: A systematic review and meta-analysis. Orphanet J Rare Dis. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Peroxisome Biogenesis Disorder 8b C3553960. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy